Sequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: A systematic review and meta-analysis.
Antonios Katsarolis(Aristotle University of Thessaloniki), Elena Fountzilas(St. Luke's Hospital), Abraham Pouliakis(National and Kapodistrian University of Athens), Μaria Anastasiou(National and Kapodistrian University of Athens), Amanda Psyrri(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
|Journal of Clinical Oncology|2010|488
Clinical trial design in the era of precision medicine
|Genome Medicine|2022|279
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
|Cancer Research|2011|266
Convergence of evolving artificial intelligence and machine learning techniques in precision oncology
|npj Digital Medicine|2025|152